{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:08:31Z","timestamp":1793761711340,"version":"4.6.1"},"reference-count":127,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA054796"],"award-info":[{"award-number":["F31DA054796"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA033934"],"award-info":[{"award-number":["P30DA033934"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3\/UH3DA050311"],"award-info":[{"award-number":["UG3\/UH3DA050311"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA054785"],"award-info":[{"award-number":["UG3DA054785"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2024,6,13]]},"DOI":"10.1021\/acs.jmedchem.4c00646","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T12:53:44Z","timestamp":1717073624000},"page":"9552-9574","source":"Crossref","is-referenced-by-count":11,"title":["Systematic Structure\u2013Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments"],"prefix":"10.1021","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-7118","authenticated-orcid":true,"given":"Celsey M.","family":"St. Onge","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23219, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4848-2673","authenticated-orcid":true,"given":"Piyusha P.","family":"Pagare","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23219, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23219, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Arriaga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando E.","family":"Mendez","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Halquist","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"Selley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Dewey","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-5246","authenticated-orcid":true,"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-7016","authenticated-orcid":true,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, Virginia 23219, United States"},{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, 410 North 12th Street, Richmond, Virginia 23298, United States"},{"name":"Institute for Drug and Alcohol Studies, 203 East Cary Street, Richmond, Virginia 23298, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"ref1\/cit1","unstructured":"Thomas, D.; Wessel, C. State of Innovation in Pain and Addiction, 2023. www.bio.org\/iareports."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216308098800"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.08.012"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn419"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.97229"},{"issue":"2","key":"ref6\/cit6","first-page":"e41","volume":"6","author":"Kenan K.","year":"2012","journal-title":"Open Med."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1021\/jm5006463"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1346"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9105-4"},{"key":"ref10\/cit10","unstructured":"Naloxone. Substance Abuse and Mental Health\nServices Administration 2021. Https:\/\/Www.Samhsa.Gov\/Medication-Assisted-Treatment\/Medications-Counseling-Related-Conditions\/Naloxone (accessed September 28, 2021)."},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/9781118454503.ch45","volume-title":"Alcohol and Drug Misuse","author":"Abraha I.","year":"2012"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.118810"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2002.tb00235.x"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000134"},{"key":"ref15\/cit15","unstructured":"Larsen, D.; Christopher; Maani, V. Nalbuphine Continuing Education Activity, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534283\/."},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/jm980724+"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj080114"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260880"},{"key":"ref19\/cit19","unstructured":"Premium\nInsights Likelihood of Approval and Phase Transition\nSuccess Rate Model-Cebranopadol in Substance (Drug) Abuse Related\nCompany Profiles Tris Pharma Inc View All, 2024. https:\/\/www.pharmaceutical-technology.com\/data-insights\/cebranopadol-tris-pharma-substance-drug-abuse-likelihood-of-approval\/."},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27133987"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00611"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00417"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.139"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1097\/ajp.0b013e3181c49e3a"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0b013e318238bba6"},{"key":"ref26\/cit26","doi-asserted-by":"crossref","unstructured":"Miaskowski, C.; Taiwo, Y. O.; Levine, J. D. K-And B-Opioid Agonists Synergize to Produce Potent Analgesia, 1990; Vol. 509.","DOI":"10.1016\/0006-8993(90)90327-8"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S262303"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00526"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108445"},{"key":"ref30\/cit30","volume-title":"Topics in Current Chemistry","volume":"299","author":"Samoson A.","year":"2011"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S145720"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp588"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S55942"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.46.366"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1159\/000341268"},{"key":"ref36\/cit36","unstructured":"TRK-820 Study in Subjects on Hemodialysis with or without Uremic\nPruritus. Clinical Trials.Gov Identifier: NCT03002233. Updated July\n21, 2017. Accessed May 6, 2024."},{"key":"ref37\/cit37","unstructured":"Safety Study of TRK-820 for Patients with Hemodialysis. Clinicaltrials.Gov\nIdentifier: NCT01248650. Updated November 25, 2010. Accessed May 6, 2024."},{"key":"ref38\/cit38","unstructured":"A Multi-Site Bridging Study\nof Nalfurafine Hydrochloride Orally Disintegrating\nTablet. Clinicaltrials.Gov Identifier: NCT04728984. Updated January\n28, 2021. Accessed May 6, 2024."},{"key":"ref39\/cit39","unstructured":"Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in\nSubjects with End-Stage Renal Disease Receiving Hemodialysis. Clinicaltrials.Gov\nIdentifier: NCT01660243. Updated February 9, 2022. Accessed May 6, 2024."},{"key":"ref40\/cit40","unstructured":"Efficacy and Safety Study\nof TRK-820 to Treat Conventional-Treatment-Resistant\nPruritus in Patients Receiving Hemodialysis. Clinicaltrials.Gov Identifier:\nNCT01513161. Updated January 20, 2012. Accessed\nMay 6, 2024."},{"key":"ref41\/cit41","unstructured":"A Randomized-Withdrawal\nPhase 3 Study Evaluating the Safety and Efficacy\nof Oral Nalfurafine HCl (AC-820) in Subjects on Hemodialysis with\nUremic Pruritus (Renal Itch). Clinicaltrials.Gov Identifier: NCT00793156.\nUpdated February 4, 2010. Accessed May 6, 2024."},{"key":"ref42\/cit42","unstructured":"Nalfurafine Hydrochloride for Pruritus in Patients with Primary\nBiliary\nCholangitis. Clinicaltrials.Gov Identifier: NCT02659696. Updated April\n26, 2018. Accessed May 6, 2024."},{"key":"ref43\/cit43","unstructured":"Phase II Study of TRK-820 Soft Capsules\u2500Intractable Pruritus\nin Patients with Chronic Liver Disease. Clinicaltrials.Gov Identifier:\nNCT00638495. Updated February 1, 2010. Accessed\nMay 6, 2024."},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00417-8"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.85.282"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00815-8"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0155-0"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4652-3"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.255661"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)00957-2"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14033"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1028-z"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000581"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01588-6"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-008-0358-8"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.01.016"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3954"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1124\/mol.113.088880"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.09.101"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00407"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2015.09.010"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.072801"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5b00092"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.2174\/138161281942140105165011"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c12-00336"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.05.122"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.02.082"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.08.036"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.09.011"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.52.664"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.06.017"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.10.100"},{"key":"ref73\/cit73","unstructured":"Cashman, J. Synthesis of metabolically stable agents for alcohol and drug abuse. WO 2010006119 Al, 2010."},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.09.029"},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.11.027"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.068"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0308"},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00087"},{"key":"ref79\/cit79","unstructured":"ACD Percepta Software\nReference: ACD\/Percepta. version\n2020.1.2; Advanced Chemistry Development, Inc.: Toronto, ON, Canada, 2020. Www.Acdlabs.Com."},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1517\/17460441003605098"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-409x(00)00129-0"},{"key":"ref82\/cit82","first-page":"25","volume":"1","author":"Manallack D. T.","year":"2007","journal-title":"Perspect. Med. Chem."},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1021\/jm000942e"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.11.047"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.03.013"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01158"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00038"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01767"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172812"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1021\/jm301247n"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.07.043"},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.05.075"},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.06.135"},{"key":"ref94\/cit94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.04.041"},{"key":"ref95\/cit95","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5b00245"},{"key":"ref96\/cit96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.02.055"},{"key":"ref97\/cit97","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetlet.2020.152379"},{"key":"ref98\/cit98","doi-asserted-by":"publisher","DOI":"10.1002\/chem.201804790"},{"key":"ref99\/cit99","doi-asserted-by":"publisher","DOI":"10.1021\/jm801272c"},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.02.055"},{"key":"ref101\/cit101","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00349"},{"key":"ref102\/cit102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.011"},{"key":"ref103\/cit103","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4119.1359"},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007138"},{"key":"ref105\/cit105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.12.093"},{"issue":"1","key":"ref106\/cit106","first-page":"22","volume":"3","author":"Gomaa A. A.","year":"1990","journal-title":"J. Islam. Acad. Sci."},{"key":"ref107\/cit107","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05519-7"},{"key":"ref108\/cit108","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4758-7"},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000326"},{"key":"ref110\/cit110","first-page":"494","volume":"220","author":"Ward S. J.","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref111\/cit111","first-page":"255","volume":"246","author":"Takemori A. E.","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref112\/cit112","doi-asserted-by":"crossref","unstructured":"Portoghese, P. S.; Sultana, M.; Takemori, A. E. Rapid Communication Naltrindole, a Highly Selective and Potent Non-peptide 8 Opioid Receptor Antagonist, 1988; Vol. 146.","DOI":"10.1016\/0014-2999(88)90502-X"},{"key":"ref113\/cit113","first-page":"137","volume-title":"Handbook of Experimental Pharmacology","volume":"271","author":"Zhou Y.","year":"2022"},{"key":"ref114\/cit114","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.964724"},{"key":"ref115\/cit115","doi-asserted-by":"publisher","DOI":"10.12703\/P7-56"},{"key":"ref116\/cit116","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0356-1"},{"key":"ref117\/cit117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109110"},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/281768"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2015.11.008"},{"key":"ref120\/cit120","doi-asserted-by":"publisher","DOI":"10.5414\/CP201852"},{"key":"ref121\/cit121","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2010.138"},{"key":"ref122\/cit122","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420118-7.00012-3"},{"key":"ref123\/cit123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.837671"},{"key":"ref124\/cit124","doi-asserted-by":"publisher","DOI":"10.1126\/science.7604285"},{"key":"ref125\/cit125","volume-title":"Relationship between the Inhibition Constant and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (Iso) of an Enzymatic Reaction*","volume":"22","author":"Cheng Y.-C.","year":"1973"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.006"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.2174\/1872312810666160223121836"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c00646","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c00646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T08:50:08Z","timestamp":1718268608000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.4c00646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":127,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,13]]}},"alternative-id":["10.1021\/acs.jmedchem.4c00646"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00646","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}